课题基金 / 基金详情

ImplemeNting a Sudden cardiac dEath Risk assessment Tool in childhood hypertrophic cardiomyopathy (INSERT-HCM)

ImplemeNting a Sudden cardiac dEath Risk assessment Tool in childhood hypertrophic cardiomyopathy (INSERT-HCM)
在儿童肥厚型心肌病中实施心源性猝死风险评估工具 (INSERT-HCM)
批准号:
462651
负责人:
Mital Seema
金额:
$45.98万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-03-01 至 2025-03-01

项目摘要

项目成果

Mital Seema的其他基金

相似基金

相关文献

中文摘要
翻译
猝死是肥厚性心肌病的毁灭性后果,肥厚性心肌病是一种遗传性心肌疾病。它是年轻运动员猝死的头号原因。通过及时插入一种名为可植入的救生装置,可以防止猝死
英文摘要
Sudden death is a devastating outcome of hypertrophic cardiomyopathy, a genetic disease of heart muscle. It is the #1 cause of sudden death in young athletes. Sudden death can be prevented by timely insertion of a life-saving device called an implantable
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A role for novel regulatory variants in childhood cardiomyopathy
PeRsOnalized genomics for CongEnital hEart Disease
Personalized Medicine in the Care of the Child with Heart Disease: Discovery to Application
  • 批准号:
    264251
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $1.71万
  • 财政年份:
    2012
  • 负责人:
    Mital Seema
  • 依托单位:
海外基金